Annual Net Income
-$8.36 M
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual net profit is currently -$8.36 millionCVKD annual net income is now at all-time high.CVKD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.41 M
-$14.80 K-0.62%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly net profit is currently -$2.41 million, with the most recent change of -$14.80 thousand (-0.62%) on 01 September 2024. Over the past year, it has dropped by -$1.37 million (-132.30%). CVKD quarterly net income is now -1263.42% below its all-time high of -$176.60 thousand, reached on 31 March 2022.CVKD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$7.61 M
-$1.37 M-21.99%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock TTM net profit is currently -$7.61 million, with the most recent change of -$1.37 million (-21.99%) on 01 September 2024. Over the past year, it has dropped by -$395.10 thousand (-5.48%). CVKD TTM net income is now -4208.15% below its all-time high of -$176.60 thousand, reached on 31 March 2022.CVKD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -132.3% | -5.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CVKD Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | -1263.4% | +53.5% | -4208.1% | +9.0% |
| 5 y | 5 years | at high | at low | -1263.4% | +53.5% | -4208.1% | +9.0% |
| alltime | all time | at high | at low | -1263.4% | +53.5% | -4208.1% | +9.0% |
Cadrenal Therapeutics Common Stock Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.41 M(+0.6%) | -$7.61 M(+22.0%) |
| June 2024 | - | -$2.39 M(+43.9%) | -$6.24 M(+28.7%) |
| Mar 2024 | - | -$1.66 M(+45.4%) | -$4.85 M(-42.0%) |
| Dec 2023 | -$8.36 M | -$1.14 M(+10.4%) | -$8.36 M(+15.9%) |
| Sept 2023 | - | -$1.04 M(+3.3%) | -$7.21 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$1.00 M(-80.6%) | -$7.20 M(+7.5%) |
| Mar 2023 | - | -$5.17 M(+404.2%) | -$6.70 M(+293.1%) |
| Sept 2022 | - | -$1.03 M(+104.4%) | -$1.70 M(+151.2%) |
| June 2022 | - | -$502.10 K(+184.3%) | -$678.70 K(+284.3%) |
| Mar 2022 | - | -$176.60 K | -$176.60 K |
FAQ
- What is Cadrenal Therapeutics Common Stock annual net profit?
- What is the all time high annual net income for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly net profit?
- What is the all time high quarterly net income for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly net income year-on-year change?
- What is Cadrenal Therapeutics Common Stock TTM net profit?
- What is the all time high TTM net income for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock TTM net income year-on-year change?
What is Cadrenal Therapeutics Common Stock annual net profit?
The current annual net income of CVKD is -$8.36 M
What is the all time high annual net income for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual net profit is -$8.36 M
What is Cadrenal Therapeutics Common Stock quarterly net profit?
The current quarterly net income of CVKD is -$2.41 M
What is the all time high quarterly net income for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly net profit is -$176.60 K
What is Cadrenal Therapeutics Common Stock quarterly net income year-on-year change?
Over the past year, CVKD quarterly net profit has changed by -$1.37 M (-132.30%)
What is Cadrenal Therapeutics Common Stock TTM net profit?
The current TTM net income of CVKD is -$7.61 M
What is the all time high TTM net income for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high TTM net profit is -$176.60 K
What is Cadrenal Therapeutics Common Stock TTM net income year-on-year change?
Over the past year, CVKD TTM net profit has changed by -$395.10 K (-5.48%)